Michael Grissinger

Mr. Michael Grissinger is an Independent Director at Adicet Bio, Inc., an Independent Director at Aprea Therapeutics, Inc. and a Chairman at Kira Biotech Pty Ltd. He is on the Board of Directors at Adicet Bio, Inc., Aprea Therapeutics, Inc., Atriva Therapeutics GmbH, Atrin Pharmaceuticals LLC, AnaCardio AB, Envisagenics, Inc. and NephroDI Therapeutics, Inc. Mr. Grissinger was previously employed as an Independent Director by resTORbio, Inc., an Independent Director by Akari Therapeutics Plc, a Member-Management Board by Janssen Pharmaceuticals, Inc., and a VP, Head-Pharmaceutical Corporate Development by Johnson & Johnson.
He also served on the board at Atrin Pharmaceuticals, Inc. He received his undergraduate degree from Juniata College and an MBA from Fox School of Business.